Also called TCRBV13S1 Vβ13 is a complex subfamily of the T cell receptor.  Vβ13.1 is expressed by 1.8% to 3.3% of peripheral CD3+ cells in normal blood. This sequence is also referred to as TRBV6-5, TRBV6-6, TRBV6-9 (based on the IMGT gene nomenclature).

Specifications

Specificity TCR Vβ13.1
Form PE
Clone IMMU 222
Flow Product Line IOTest
Clone Description The IMMU 222 antibody recognizes VB13.1 member (HBP34 sequence). VB13.3 (IGRb14 sequence) is not recognized. Reactivity with other members of this subfamily has not been found, but cannot be formally excluded. It has been recently shown that Immu 222 can recognize the VB13.4 and VB13.6 (IGRb16 sequence) subsets.
Isotype IgG2b Mouse
Format Liquid
Size 1 mL
Regulatory Status ASR
Target Species Human
Other Names TCR VBeta 13.1, TCRBV13S1
UNSPSC 41116015

NOT ALL PRODUCTS ARE AVAILABLE IN ALL COUNTRIES
PRODUCT AVAILABILITY AND REGULATORY STATUS DEPENDS ON COUNTRY REGISTRATION PER APPLICABLE REGULATIONS

The listed regulatory status for products correspond to one of the below:
IVD: In Vitro Diagnostic Products. These products are labeled "For In Vitro Diagnostic Use."
ASR: Analyte Specific Reagents. These reagents are labeled "Analyte Specific Reagents. Analytical and performance characteristics are not established."
CE: Products intended for in vitro diagnostic use and conforming to European Directive (98/79/EC). (Note: Devices may be CE marked to other directives than (98/79/EC)
RUO: Research Use Only. These products are labeled "For Research Use Only. Not for use in diagnostic procedures."
LUO: Laboratory Use Only. These products are labeled "For Laboratory Use Only."
No Regulatory Status: Non-Medical Device or non-regulated articles. Not for use in diagnostic or therapeutic procedures.